| 貨號 | 規(guī)格 | 價格 | 上海 | 北京 | 武漢 | 南京 | 購買數(shù)量 |
|---|---|---|---|---|---|---|---|
| S83225-1mg | 98% | ￥1100.00 | 貨期：2-3天 | - | - | - |
|
| S83225-2mg | 98% | ￥1500.00 | 貨期：2-3天 | - | - | - |
|
| S83225-5mg | 98% | ￥2100.00 | 貨期：2-3天 | - | - | - |
|
| S83225-10mg | 98% | ￥3500.00 | 貨期：2-3天 | - | - | - |
|
| S83225-25mg | 98% | ￥6200.00 | 貨期：2-3天 | - | - | - |
|
| S83225-50mg | 98% | ￥10500.00 | 貨期：2-3天 | - | - | - |
|
| S83225-100mg | 98% | ￥16100.00 | 貨期：2-3天 | - | - | - |
|
RI-2 is a reversible RAD51 inhibitor, with an IC50 of 44.17 μM, and specifically inhibits homologous recombination repair in human cells.
| 產(chǎn)品描述： | RI-2 is a reversible RAD51 inhibitor, with an IC50 of 44.17 μM, and specifically inhibits homologous recombination repair in human cells. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點： | IC50: 44.17 μM (RAD51);DNA/RNASynthesis | ||||||||||||||||||||
| 體外研究： | RI-2 (7a) is a reversible RAD51 inhibitor, with an IC50 of 44.17 μM. RI-2 specifically inhibits homologous recombination repair in human cells. RI-2 (150 μM) induces a significant sensitization of cells | ||||||||||||||||||||
| 參考文獻： | 1. Budke B, et al. An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. J Med Chem. 2013 Jan 10;56(1):254-63. | ||||||||||||||||||||
| 溶解性： | soluble in DMSO | ||||||||||||||||||||
| 保存條件： | -20℃ | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網(wǎng)安備 31011702002021號
危險品化學品經(jīng)營許可證（不帶存儲）
營業(yè)執(zhí)照(三證合一)
北京